Personalised medicine in psychiatry and psychotherapy: A review of the current state-of-the-art in the biomarker-based early recognition of psychoses;Personalisierte Medizin in der Psychiatrie und Psychotherapie: Ein Überblick über mögliche Biomarker-gestützte Methoden zur Früherkennung von Psychosen

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 56, Issue 11, 2013, Pages 1522-1530

  Koutsouleris, N ^a   Ruhrmann, S ^b   Falkai, P ^a   Maier, W ^c  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c UNIVERSITY OF BONN   (Germany)

Author keywords

Biomarker; Early recognition; Machine learning methods; Personalized risk stratification; Psychosis

Indexed keywords

BIOLOGICAL MARKER;

EARLY DIAGNOSIS; HUMAN; METABOLISM; METHODOLOGY; MOLECULAR PATHOLOGY; PERSONALIZED MEDICINE; PSYCHOSIS; REVIEW;

BIOLOGICAL MARKERS; EARLY DIAGNOSIS; HUMANS; INDIVIDUALIZED MEDICINE; PATHOLOGY, MOLECULAR; PSYCHOTIC DISORDERS;

EID: 84887426500     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-013-1840-0     Document Type: Review

References (89)

1. Correll CU, Hauser M, Auther AM et al (2010) Research in people with psychosis risk syndrome: a review of the current evidence and future directions. J Child Psychol Psychiatry 51:390-431
2. McGorry PD, Nelson B, Amminger GP et al (2009) Intervention in individuals at ultra high risk for psychosis: a review and future directions. J Clin Psychiatry 70:1206-1212
3. WHO (2008) The global burden of disease: update 2004. http://www.who.int/topics/global-burden-of-disease/en/
4. Barbato A (1998) Schizophrenia and public health
5. Gustavsson A, Svensson M, Jacobi F et al (2011) Cost of disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 21:718-779
6. Preti A, Cella M (2010) Randomized-controlled trials in people at ultra high risk of psychosis: a review of treatment effectiveness. Schizophr Res 123:30-36
7. Häfner H, Riecher-Rössler A, Hambrecht M et al (1992) IRAOS: an instrument for the assessment of onset and early course of schizophrenia. Schizophr Res 6:209-223
8. Häfner H, Heiden Wander (1999) The course of schizophrenia in the light of modern follow-up studies: the ABC and WHO studies. Eur Arch Psychiatry Clin Neurosci 249(Suppl 4):14-26
9. Schultze-Lutter F, Addington J, Ruhrmann S et al (2007) Schizophrenia Proneness Instrument, Adult Version (SPI-A)
10. Yung AR, Yuen HP, McGorry PD et al (2005) Mapping the onset of psychosis: the comprehensive assessment of at-risk mental states. Aust N Z J Psychiatry 39:964-971
11. Fusar-Poli P, Bonoldi I, Yung AR et al (2012) Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk. Arch Gen Psychiatry 69:220-229
12. Johns LC, Cannon M, Singleton N et al (2004) Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry 185:298-305
13. Johns LC, Nazroo JY, Bebbington P et al (2002) Occurrence of hallucinatory experiences in a community sample and ethnic variations. Br J Psychiatry 180:174-178
14. Hlastala SA, McClellan J (2005) Phenomenology and diagnostic stability of youths with atypical psychotic symptoms. J Child Adolesc Psychopharmacol 15:497-509
15. Yung AR, Yuen HP, Berger G et al (2007) Declining transition rate in ultra high risk (prodromal) services: dilution or reduction of risk? Schizophr Bull 33:673-681
16. Klosterkötter J, Hellmich M, Steinmeyer EM et al (2001) Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry 58:158-164
17. Huber G (1966) Reine Defektsyndrome und Basisstadien endogener Psychosen. Fortschr Neurol Psychiatr 34:409-426
18. Cannon TD, Cadenhead K, Cornblatt B et al (2008) Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry 65:28-37
19. Ruhrmann S, Schultze-Lutter F, Salokangas RKR et al (2010) Prediction of psychosis in adolescents and young adults at high risk: results from the prospective European prediction of psychosis study. Arch Gen Psychiatry 67:241-251
20. Heinrichs RW, Zakzanis KK (1998) Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12:426-445
21. Hofer A, Baumgartner S, Bodner T et al (2005) Patient outcomes in schizophrenia II: the impact of cognition. Eur Psychiatry 20:395-402
22. Keefe RSE, Seidman LJ, Christensen BK et al (2004) Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol. Am J Psychiatry 16:985-995
23. Wölwer W, Brinkmeyer J, Riesbeck M et al (2008) Neuropsychological impairments predict the clinical course in schizophrenia. Eur Arch Psychiatry Clin Neurosci 258(Suppl 5):28-34
24. Pena J, Ojeda N, Segarra R et al (2011) Executive functioning correctly classified diagnoses in patients with first-episode psychosis: evidence from a 2-year longitudinal study. Schizophr Res 126:77-80
25. Erlenmeyer-Kimling L, Rock D, Roberts SA et al (2000) Attention, memory, and motor skills as childhood predictors of schizophrenia-related psychoses: the New York High-Risk Project. Am J Psychiatry 157:1416-1422
26. Faraone SV, Seidman LJ, Kremen WS et al (1999) Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a 4-year follow-up study. J Abnorm Psychol 108:176-181
27. Owens DGC, Johnstone EC (2006) Precursors and prodromata of schizophrenia: findings from the Edinburgh High Risk Study and their literature context. Psychol Med 36:1501-1514
28. Blanchard MM, Jacobson S, Clarke MC et al (2010) Language, motor and speed of processing deficits in adolescents with subclinical psychotic symptoms. Schizophr Res 123:71-76
29. Brewer WJ, Francey SM, Wood SJ et al (2005) Memory impairments identified in people at ultra-high risk for psychosis who later develop first-episode psychosis. Am J Psychiatry 162:71-78
30. Hawkins KA, Addington J, Keefe RSE et al (2004) Neuropsychological status of subjects at high risk for a first episode of psychosis. Schizophr Res 67:115-122
31. Niendam TA, Bearden CE, Johnson JK et al (2006) Neurocognitive performance and functional disability in the psychosis prodrome. Schizophr Res 84:100-111
32. Wood SJ, Brewer WJ, Koutsouradis P et al (2007) Cognitive decline following psychosis onset: data from the PACE clinic. Br J Psychiatry Suppl 51:s52-s57
33. Pukrop R, Schultze-Lutter F, Ruhrmann S et al (2006) Neurocognitive functioning in subjects at risk for a first episode of psychosis compared with first-and multiple-episode schizophrenia. J Clin Exp Neuropsychol 28:1388-1407
34. Frommann I, Pukrop R, Brinkmeyer J et al (2010) Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early-and additional memory dysfunction in the late-prodromal state. Schizophr Bull 37:861-873
35. Lencz T, Smith CW, Auther A et al (2004) Nonspecific and attenuated negative symptoms in patients at clinical high-risk for schizophrenia. Schizophr Res 68:37-48
36. Riecher-Rössler A, Pflueger MO, Aston J et al (2009) Efficacy of using cognitive status in predicting psychosis: a 7-year follow-up. Biol Psychiatry 66:1023-1030
37. Koutsouleris N, Davatzikos C, Bottlender R et al (2012) Early recognition and disease prediction in the at-risk mental states for psychosis using neurocognitive pattern classification. Schizophr Bull 38:1200-1215
38. Noble WS (2006) What is a support vector machine? Nat Biotechnol 24:1565-1567
39. Vapnik VN (1999) An overview of statistical learning theory. IEEE Trans Neural Netw 10:988-999
40. Seidman LJ, Giuliano AJ, Meyer EC et al (2010) Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Arch Gen Psychiatry 67:578-588
41. Walder DJ, Mittal V, Trotman HD et al (2008) Neurocognition and conversion to psychosis in adolescents at high-risk. Schizophr Res 101:161-168
42. Olvet DM, Stearns WH, McLaughlin D et al (2010) Comparing clinical and neurocognitive features of the schizophrenia prodrome to the bipolar prodrome. Schizophr Res 123:59-63
43. Zimmermann R, Gschwandtner U, Wilhelm FH et al (2010) EEG spectral power and negative symptoms in at-risk individuals predict transition to psychosis. Schizophr Res 123:208-216
44. Bramon E, Rabe-Hesketh S, Sham P et al (2004) Meta-analysis of the P300 and P50 waveforms in schizophrenia. Schizophr Res 70:315-329
45. Tricht MJ van, Nieman DH, Koelman JHTM et al (2010) Reduced parietal P300 amplitude is associated with an increased risk for a first psychotic episode. Biol Psychiatry 68:642-648
46. Umbricht D, Krljes S (2005) Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res 76:1-23
47. Bodatsch M, Ruhrmann S, Wagner M et al (2011) Prediction of psychosis by mismatch negativity. Biol Psychiatry 69:959-966
48. Higuchi Y, Sumiyoshi T, Seo T et al (2013) Mismatch negativity and cognitive performance for the prediction of psychosis in subjects with at-risk mental state. PLoS One 8:e54080
49. Shaikh M, Valmaggia L, Broome MR et al (2012) Reduced mismatch negativity predates the onset of psychosis. Schizophr Res 134:42-48
50. Ruhrmann S, Klosterkötter J, Bodatsch M et al (2012) Chances and risks of predicting psychosis. Eur Arch Psychiatry Clin Neurosci 262(Suppl 2):585-590
51. Keshavan MS, Tandon R, Boutros NN et al (2008) Schizophrenia, .,just the facts": what we know in 2008 Part 3: neurobiology. Schizophr Res 106:89-107
52. Wright IC, Rabe-Hesketh S, Woodruff PW et al (2000) Meta-analysis of regional brain volumes in schizophrenia. Am J Psychiatry 157:16-25
53. Good CD, Johnsrude IS, Ashburner J et al (2001) A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14:21-36
54. Ashburner J, Friston KJ (2005) Unified segmentation. Neuroimage 26:839-851
55. Honea R, Crow TJ, Passingham D et al (2005) Regional deficits in brain volume in schizophrenia: a meta-analysis of voxel-based morphometry studies. Am J Psychiatry 162:2233-2245
56. Meisenzahl EM, Koutsouleris N, Bottlender R et al (2008) Structural brain alterations at different stages of schizophrenia: a voxel-based morphometric study. Schizophr Res 104:44-60
57. Olabi B, Ellison-Wright I, McIntosh AM et al (2011) Are there progressive brain changes in schizophrenia? A meta-analysis of structural magnetic resonance imaging studies. Biol Psychiatry 70:88-96
58. Davatzikos C, Shen D, Gur RC et al (2005) Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry 62:1218-1227
59. Kawasaki Y, Suzuki M, Kherif F et al (2007) Multivariate voxel-based morphometry successfully differentiates schizophrenia patients from healthy controls. Neuroimage 34:235-242
60. Nakamura K, Kawasaki Y, Suzuki M et al (2004) Multiple structural brain measures obtained by three-dimensional magnetic resonance imaging to distinguish between schizophrenia patients and normal subjects. Schizophr Bull 30:393-404
61. Sun D, Erp TGM van, Thompson PM et al (2009) Elucidating a magnetic resonance imaging-based neuroanatomic biomarker for psychosis: classification analysis using probabilistic brain atlas and machine learning algorithms. Biol Psychiatry 66:1055-1060
62. Takayanagi Y, Kawasaki Y, Nakamura K et al (2010) Differentiation of first-episode schizophrenia patients from healthy controls using ROI-based multiple structural brain variables. Prog Neuropsychopharmacol Biol Psychiatry 34:10-17
63. Nieuwenhuis M, Haren NEM van, Hulshoff Pol HE et al (2012) Classification of schizophrenia patients and healthy controls from structural MRI scans in two large independent samples. Neuroimage 61:606-612
64. Koutsouleris N, Gaser C, Jäger M et al (2008) Structural correlates of psychopathological symptom dimensions in schizophrenia: a voxel-based morphometric study. Neuroimage 39:1600-1612
65. Lui S, Deng W, Huang X et al (2009) Neuroanatomical differences between familial and sporadic schizophrenia and their parents: an optimized voxel-based morphometry study. Psychiatry Res 171:71-81
66. Nenadic I, Sauer H, Gaser C (2010) Distinct pattern of brain structural deficits in subsyndromes of schizophrenia delineated by psychopathology. Neuroimage 49:1153-1160
67. Suzuki M, Zhou SY, Hagino H et al (2005) Morphological brain changes associated with Schneider's first-rank symptoms in schizophrenia: a MRI study. Psychol Med 35:549-560
68. Ho BC, Andreasen NC, Ziebell S et al (2011) Long-term antipsychotic treatment and brain volumes: a longitudinal study of first-episode schizophrenia. Arch Gen Psychiatry 68:128-137
69. James A, Hough M, James S et al (2011) Greater white and grey matter changes associated with early cannabis use in adolescent-onset schizophrenia (AOS). Schizophr Res 128:91-97
70. Konopaske GT, Dorph-Petersen KA, Pierri JN et al (2007) Effect of chronic exposure to antipsychotic medication on cell numbers in the parietal cortex of macaque monkeys. Neuropsychopharmacology 32:1216-1223
71. Konopaske GT, Dorph-Petersen KA, Sweet RA et al (2008) Effect of chronic antipsychotic exposure on astrocyte and oligodendrocyte numbers in macaque monkeys. Biol Psychiatry 63:759-765
72. Borgwardt SJ, Riecher-Rössler A, Dazzan P et al (2007) Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry 61:1148-1156
73. Ho BC (2007) MRI brain volume abnormalities in young, nonpsychotic relatives of schizophrenia probands are associated with subsequent prodromal symptoms. Schizophr Res 9:1-13
74. Meisenzahl EM, Koutsouleris N, Gaser C et al (2008) Structural brain alterations in subjects at high-risk of psychosis: a voxel-based morphometric study. Schizophr Res 102:150-162
75. Pantelis C, Velakoulis D, McGorry PD et al (2003) Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison. Lancet 361:281-288
76. Fusar-Poli P, Borgwardt S, Crescini A et al (2011) Neuroanatomy of vulnerability to psychosis: a voxel-based meta-analysis. Neurosci Biobehav Rev 35:1175-1185
77. Smieskova R, Fusar-Poli P, Allen P et al (2010) Neuroimaging predictors of transition to psychosis-a systematic review and meta-analysis. Neurosci Biobehav Rev 34:1207-1222
78. Fusar-Poli P, Broome MR, Matthiasson P et al (2011) Prefrontal function at presentation directly related to clinical outcome in people at ultrahigh risk of psychosis. Schizophr Bull 37:189-198
79. Allen P, Luigjes J, Howes OD et al (2012) Transition to psychosis associated with prefrontal and subcortical dysfunction in ultra high-risk individuals. Schizophr Bull 38:1268-1276
80. Howes O, Bose S, Turkheimer F et al (2011) Progressive increase in striatal dopamine synthesis capacity as patients develop psychosis: a PET study. Mol Psychiatry 16:885-886
81. Fusar-Poli P, Howes OD, Allen P et al (2010) Abnormal frontostriatal interactions in people with prodromal signs of psychosis: a multimodal imaging study. Arch Gen Psychiatry 67:683-691
82. Stone JM, Howes OD, Egerton A et al (2010) Altered relationship between hippocampal glutamate levels and striatal dopamine function in subjects at ultra high risk of psychosis. Biol Psychiatry 68:599-602
83. Stone JM, Day F, Tsagaraki H et al (2009) Glutamate dysfunction in people with prodromal symptoms of psychosis: relationship to gray matter volume. Biol Psychiatry 66:533-539
84. Davatzikos C (2004) Why voxel-based morphometric analysis should be used with great caution when characterizing group differences. Neuroimage 23:17-20
85. Koutsouleris N, Meisenzahl EM, Davatzikos C et al (2009) Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition. Arch Gen Psychiatry 66:700-712
86. Koutsouleris N, Borgwardt S, Meisenzahl EM et al (2012) Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study. Schizophr Bull 38:1234-1246
87. Borgwardt S, Koutsouleris N, Aston J et al (2012) Distinguishing prodromal from first-episode psychosis using neuroanatomical single-subject pattern recognition. Schizophr Bull (im Druck)
88. Wood SJ, Yung AR, McGorry PD, Pantelis C (2011) Neuroimaging and treatment evidence for clinical staging in psychotic disorders: from the at-risk mental state to chronic schizophrenia. Biol Psychiatry 70:619-625
89. Ivleva EI, Morris DW, Moates AF et al (2010) Genetics and intermediate phenotypes of the schizophrenia-bipolar disorder boundary. Neurosci Biobehav Rev 34:897-921